Acrolein inactivates paraoxonase 1: changes in free acrolein levels after hemodialysis correlate with increases in paraoxonase 1 activity in chronic renal failure patients

被引:39
作者
Gugliucci, Alejandro
Lunceford, Nicole
Kinugasa, Eriko
Ogata, Hiroaki
Schulze, John
Kimura, Satoshi
机构
[1] Touro Univ California, Div Basic Med Sci, Glycat Oxidat & Dis Lab, Vallejo, CA 94592 USA
[2] Showa Univ, Northern Yokohama Hosp, Dept Internal Med, Tsuzuki Ku, Yokohama, Kanagawa 227, Japan
[3] Showa Univ, Northern Yokohama Hosp, Dept Lab Med, Tsuzuki Ku, Yokohama, Kanagawa 227, Japan
[4] Showa Univ, Northern Yokohama Hosp, Cent Clin Lab, Tsuzuki Ku, Yokohama, Kanagawa 227, Japan
关键词
oxidative stress; HDL; uremia; maillard reaction; paraoxonase; 1; atherosclerosis; chronic renal failure; carbonyl stress; APOLIPOPROTEIN-A-I; CIGARETTE-SMOKE; N-ACETYLCYSTEINE; CARDIOVASCULAR-DISEASES; OXIDANT STRESS; ATHEROSCLEROSIS; CHOLESTEROL; HDL; CONSEQUENCES; INHIBITION;
D O I
10.1016/j.cca.2007.06.012
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Acrolein is a very reactive aldehyde present in cigarette smoke and endogenously generated by pathways such as lipid peroxidation threonine metabolism by phagocytes. Acrolein has been shown to affect uptake of cholesterol by HDL. We hypothesized that acrolein could also have deleterious effects on paraoxonase 1 (PON-1) activity. We also determined whether free serum acrolein levels are higher in renal failure, and assessed whether they decrease after hemodialysis (HD) and whether this change correlates with increases in PON-1 activity. Methods: We incubated human HDL with 0-10 mmol/l acrolein for 2 h and measured PON-1 activity and structural changes. Acrolein was also measured in 40 end stage renal disease (ESRD) patients (before and after a hemodialysis session), and 40 control subjects. Results: We found that acrolein inhibits PON-1 activity in HDL in a time and concentration dependent fashion. Inhibition occurred at 40% at 0.5 mmol/l and was cancelled by cysteine but not by aminoguanidine or carnosine. We confirm that free serum acrolein levels are higher in chronic renal failure patients and demonstrate that they are partially removed by HD. Decrease in acrolein levels after dialysis correlate with increases in PON-1 activity (r=0.32, p 0.01). Conclusion: Acrolein inactivates paraoxonase 1 in HDL, a process that is inhibited by N-acetylcysteine. We confirm that acrolein levels are higher in ESRD and show for the first time, data supporting that acrolein is partially removed by hemodialysis. Decrease in acrolein levels after dialysis correlates with increase in PON-1 activity. This could offer new insights to explain low PON-1 activities in smokers and renal failure subjects as well as pointing at thiol-conserving reducing compounds such as N-acetylcysteine, as putative therapeutic palliatives. (c) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:105 / 112
页数:8
相关论文
共 38 条
[1]   N-acetylcysteine - passe-partout or much ado about nothing? [J].
Aitio, ML .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 61 (01) :5-15
[2]   FLUOROMETRIC DETERMINATION OF ACROLEIN AND RELATED COMPOUNDS WITH M-AMINOPHENOL [J].
ALARCON, RA .
ANALYTICAL CHEMISTRY, 1968, 40 (11) :1704-&
[3]   Paraoxonases and cardiovascular diseases: pharmacological and nutritional influences [J].
Aviram, M ;
Rosenblat, M .
CURRENT OPINION IN LIPIDOLOGY, 2005, 16 (04) :393-399
[4]   Paraoxonases 1, 2, and 3, oxidative stress, and macrophage foam cell formation during atherosclerosis development [J].
Aviram, M ;
Rosenblat, M .
FREE RADICAL BIOLOGY AND MEDICINE, 2004, 37 (09) :1304-1316
[5]  
Aviram M, 2002, DRUG EXP CLIN RES, V28, P49
[6]  
Beltowski Jerzy, 2005, Postepy Hig Med Dosw (Online), V59, P392
[7]   Paraoxonase activity and paraoxonase 1 gene polymorphism in patients with uremia [J].
Biasioli, S ;
Schiavon, R ;
Petrosino, L ;
De Fanti, E ;
Cavalcanti, G ;
Battaglia, P ;
Fasolin, A .
ASAIO JOURNAL, 2003, 49 (03) :295-299
[8]   Relative sensitivities of plasma lecithin:cholesterol acyltransferase, platelet-activating factor acetylhydrolase, and paraoxonase to in vitro gas-phase cigarette smoke exposure [J].
Bielicki, JK ;
Knoff, LJ ;
Tribble, DL ;
Forte, TM .
ATHEROSCLEROSIS, 2001, 155 (01) :71-78
[9]  
Cheung M C, 1986, Methods Enzymol, V129, P130
[10]   Pathophysiology of cardiovascular disease and renal failure [J].
Dikow, R ;
Zeler, M ;
Ritz, E .
CARDIOLOGY CLINICS, 2005, 23 (03) :311-+